(Q57219365)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22111816%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Calcium carbonate, but not sevelamer, is associated with better outcomes in hemodialysis patients: results from the French ARNOS study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22111816%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22111816%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Guillaume Jean

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22111816%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Dominique Lataillade

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22111816%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Leslie Genet

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22111816%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Eric Legrand

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22111816%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

François Kuentz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22111816%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Xavier Moreau-Gaudry

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22111816%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

ARNOS study investigators

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22111816%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

26 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22111816%20AND%20SRC:MED&resulttype=core&format=json

Hemodialysis International

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22111816%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22111816%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22111816%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

485-492

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22111816%20AND%20SRC:MED&resulttype=core&format=json

Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2011.00575.X

Efficacy and side-effect profile of sevelamer hydrochloride used in combination with conventional phosphate binders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2011.00575.X

A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2011.00575.X

Oral phosphate binders in patients with kidney failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2011.00575.X

Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2011.00575.X

The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2011.00575.X

Phosphorus binders and survival on hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2011.00575.X

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2011.00575.X

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2011.00575.X

Mineral and bone status in French maintenance hemodialysis patients: a comparison of June 2005 and June 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2011.00575.X

A kinetic model of inorganic phosphorus mass balance in hemodialysis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2011.00575.X

Treating mineral metabolism disorders in patients undergoing long hemodialysis: a search for an optimal strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2011.00575.X

Survival in end stage renal disease: calcium carbonate vs. sevelamer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2011.00575.X

Effects of sevelamer and calcium on coronary artery calcification in patients new to dialysis: time for better controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2011.00575.X

Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2011.00575.X

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2011.00575.X

A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2011.00575.X

Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2011.00575.X

The influence of dialysate calcium on the therapeutic effects of sevelamer hydrochloride in hemodialysis patients with secondary hyperparathyroidism under treatment of intravenous vitamin d metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2011.00575.X

Progression of calcification in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2011.00575.X

10.1111/J.1542-4758.2011.00575.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22111816%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference